首页> 美国卫生研究院文献>Journal of Psychiatry Neuroscience : JPN >Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.
【2h】

Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

机译:色氨酸联合氟西汀治疗严重抑郁症的初步随机双盲安慰剂对照试验:抗抑郁和催眠作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: Because the initial phase of treatment of depression with a selective serotonin reuptake inhibitor is often complicated by a delayed onset of action of the antidepressant or severe insomnia or both, we investigated whether tryptophan, an amino acid with both antidepressant-augmenting and hypnotic effects, would benefit patients with depression at the beginning of treatment with fluoxetine. DESIGN: Randomized, double-blind, placebo-controlled trial. PATIENTS: Thirty individuals with major depressive disorder. INTERVENTIONS: Treatment over 8 weeks with 20 mg of fluoxetine per day and either tryptophan (2 to 4 g per day) or placebo. OUTCOME MEASURES: Mood was assessed using the 29-item Hamilton Depression Rating Scale (HDRS-29) and the Beck Depression Inventory (BDI). Laboratory sleep studies were done at baseline and after 4 and 8 weeks of treatment using standard procedures. RESULTS: During the first week of treatment, there was a significantly greater decrease in HDRS-29 depression scores, and a similar trend in BDI scores, in the tryptophan/fluoxetine group than in the placebo/fluoxetine group. No significant differences were noted at later time points. With respect to sleep measures, there was a significant group-by-time interaction for slow-wave sleep at week 4. Further analysis revealed a significant decrease in slow-wave sleep after 4 weeks of treatment in the placebo/fluoxetine group, but not in the tryptophan/fluoxetine group. No cases of serotonin syndrome occurred, and the combination was well tolerated, although the 4 g per day dosage of tryptophan produced daytime drowsiness. CONCLUSIONS: Combining 20 mg of fluoxetine with 2 g of tryptophan daily at the outset of treatment for major depressive disorder appears to be a safe protocol that may have both a rapid antidepressant effect and a protective effect on slow-wave sleep. Further large-scale studies are needed to confirm these initial findings.
机译:目的:由于选择性5-羟色胺再摄取抑制剂治疗抑郁症的初始阶段通常会因抗抑郁药或严重失眠或两者的起效延迟而变得复杂,因此我们研究了色氨酸(一种同时具有抗抑郁增强和催眠作用的氨基酸) ,在开始使用氟西汀治疗后会使抑郁症患者受益。设计:随机,双盲,安慰剂对照试验。患者:30例重度抑郁症患者。干预措施:每天20 mg氟西汀和色氨酸(每天2至4 g)或安慰剂治疗8周以上。观察指标:使用29项汉密尔顿抑郁量表(HDRS-29)和贝克抑郁量表(BDI)评估情绪。使用标准程序在基线以及治疗4周和8周后进行实验室睡眠研究。结果:在治疗的第一周,色氨酸/氟西汀组的HDRS-29抑郁评分明显降低,而BDI评分的趋势比安慰剂/氟西汀组更大。在以后的时间点没有发现显着差异。关于睡眠指标,第4周的慢波睡眠存在明显的逐组交互作用。进一步的分析显示,安慰剂/氟西汀组治疗4周后,慢波睡眠显着减少,但没有在色氨酸/氟西汀组中。尽管每天服用4克色氨酸会导致白天嗜睡,但没有发生5-羟色胺综合征的病例,并且该组合耐受性良好。结论:在重度抑郁症治疗开始时,每天将20 mg氟西汀与2 g色氨酸合用似乎是安全的方案,可能具有快速的抗抑郁作用和对慢波睡眠的保护作用。需要进一步的大规模研究来确认这些初步发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号